ProPharma leads the life sciences industry, continuously advancing and strengthening its role in the field. Stay informed with the latest news and updates from ProPharma
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization.
ProPharma Recognized by PharmaTech Outlook as the World’s Premier Research Consulting Organization
RALEIGH, NC, July 26, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...
ProPharma Broadens Biostatistics and Programming Capabilities with New Hub in Hyderabad, India
RALEIGH, NC, July 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...
ProPharma Announces New Office Location in Medicon Village in Lund, Sweden
The New Office will be Located in the Ideon Science Park, the Largest Life Science Hub in Sweden. RALEIGH, NC, May 31, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting...
ProPharma Announces the Appointment of Dr. Ronald Freeze, Ph.D., as Global Head of Medical Technology
RALEIGH, NC, May 17, 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...
ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics
RALEIGH, NC, May 9, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, and H1, a leading healthcare...
ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
ProPharma buys DLC in latest services-focused takeover
On January 31st, 2023, Clinical Insider, a weekly clinical trials newsletter, published a blog post mentioning ProPharma's recent acquisition of Digital Lab Consulting (DLC) and ProPharma's release...
ProPharma Announces Acquisition of Digital Lab Consulting
PROPHARMA ANNOUNCES ACQUISITION OF UK-BASED DIGITAL LAB CONSULTING TO EXPAND R&D CAPABILITIES AND ACCELERATE PRODUCT DEVELOPMENT RALEIGH, NC, January 25, 2023: ProPharma Group (ProPharma) the...
ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
ProPharma Names Dawn Sherman Chief Executive Officer
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Expands into Central and Eastern Europe Through Acquisition of Clinres Farmacija
RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
ProPharma Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
Odyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company") from Linden Capital Partners. Financial terms of the...
ProPharma Group and The Planet Group Announce Agreement to Merge
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...